ArticleBMJ open2020
Mapping evidence on the implementation of the WHO's collaborative framework for the management of tuberculosis and diabetes: a scoping review protocol.
Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Inflammatory Markers as Predictors of Diabetes Mellitus in Patients with Pulmonary Tuberculosis: A Retrospective Analysis of Hematological Parameters and Clinical Features.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
- Implementation of the WHO's collaborative framework for the management of tuberculosis and diabetes: a scoping review.BMJ open · 2021Article
- Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus.Frontiers in physiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe emergence of tuberculosis (TB) and diabetes mellitus (DM) coepidemic threatens the gains made in fighting the prevalence of these two diseases. As a result, in 2011, WHO and the International Union Against Lung Disease launched a framework to address the growing TB-DM coepidemic across the world. The aim of the proposed review study is mapping evidence on the implementation of the WHO collaborative framework for the management of TB-DM using a scoping review. METHODOLOGY AND ANALYSIS: This study will map literature on the global implementation of the WHO collaborative framework for the management of TB-DM, using Arksey and O'Malley's scoping review framework. An extensive literature search for the peer-reviewed articles, grey literature, unpublished studies, thesis, studies in the press and a list of references from the selected studies will be conducted to find eligible studies. PubMed, Google Scholar, Web of Science, Science Direct, the EBSCOhost platform (Academic search complete, health source: nursing/academic edition, CINAHL with full text) and the WHO library will be used to source literature. The researcher will perform title screening of articles using keywords in the databases, and two independent reviewers will then screen abstracts and full articles. The screening will be guided by the inclusion and exclusion criteria. The Mixed Method Appraisal Tool V.2018 will be used to examine the quality of studies to be included. The findings will be analysed using the thematic content analysis approach and the results presented in the form of a narrative report. ETHICS AND DISSEMINATION: The study did not require ethics approval because it is a scoping review protocol. Findings from this study will be disseminated by print and electronic mediums.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.